Results 81 to 90 of about 540 (114)

Pathogen-Specific Regulation of Renin-Angiotensin System Genes in Epithelial Cells: A Comparative Study of SARS-CoV-2 Spike Protein N-Terminal Domain Fragment and Bacterial Lipopolysaccharide. [PDF]

Pathogens
Yılmaz A, Turk S, Malkan UY, Haznedaroglu İC, Gocer S, Ozguven SV, Turk C.   +6 more
europepmc   +1 more source

Low Vitamin D Status is Not Associated with the Aggressive Pathological Features of Papillary Thyroid Cancer. [PDF]

Sisli Etfal Hastan Tip Bul, 2022
Demircioglu ZG, Aygun N, Demircioglu MK, Ozguven BY, Uludag M.   +4 more
europepmc   +1 more source

Interobserver variability in dominant intraprostatic lesion delineation using ⁶⁸Ga-PSMA PET/CT for localized prostate cancer. [PDF]

Rep Pract Oncol Radiother
Devran BZ, Cetin IA, Cagliyan F, Özgüven S, Öneş T.   +4 more
europepmc   +1 more source

Location selection of field hospitals amid COVID-19 considering effectiveness and fairness: A case study of Florida. [PDF]

Int J Disaster Risk Reduct, 2023
Alisan O, Ulak MB, Ozguven EE, Horner MW.   +3 more
europepmc   +1 more source

Integrating epidemiological modeling and time-series forecasting to optimize pandemic patient allocation. [PDF]

Int J Health Geogr
Abazari S, Alisan O, Vanli OA, Ozguven EE.   +3 more
europepmc   +1 more source

Assessment of Takayasu arteritis in routine practice with PETVAS, an 18F-FDG PET quantitative scoring tool. [PDF]

Turk J Med Sci, 2022
Tahra SK, Özgüven S, Ünal AU, Öner FA, Öneş T, Erdil TY, Direskeneli H.   +6 more
europepmc   +1 more source

Comparative dosimetric study of single- vs. multi-channel cylindrical applicators in vaginal brachytherapy: Implications for organs at risk and vaginal surface doses. [PDF]

J Contemp Brachytherapy
Parlar S, Nurlu D, Cosar R, Ozguven Y.
europepmc   +1 more source

IS REPEAT FNAB NECESSARY FOR THYROID NODULES WITH ND / UNS CYTOLOGY? [PDF]

Acta Endocrinol (Buchar), 2022
Uçak R, Mut DT, Kaya C, Ozguven BY, Kabukcuoglu F, Uludağ M.   +5 more
europepmc   +1 more source

Prognostic Value of Treatment-Related Body Composition Changes in Metastatic NSCLC Receiving Nivolumab. [PDF]

Medicina (Kaunas)
Kocaaslan E, Güren AK, Akagündüz F, Demirel A, Tunç MA, Paçacı B, Ağyol Y, Erel P, Çelebi A, Işık S, Çoban E, Demircan NC, Özgüven S, Balaban Genç ZC, Majidova N, Sever N, Sarı M, Köstek O, Bayoğlu İV.   +18 more
europepmc   +1 more source

Prognostic Value of ¹⁸F-FDG PET/CT-Derived Secondary Lymphoid Organ Ratios and Hematologic Inflammation Markers in Advanced Non-Small Cell Lung Cancer Treated with Nivolumab. [PDF]

J Clin Med
Kocaaslan E, Güren AK, Akagündüz F, Demirel A, Tunç MA, Paçacı B, Ağyol Y, Erel P, Çelebi A, Işık S, Çoban E, Demircan NC, Özgüven S, Balaban Genç ZC, Majidova N, Sever N, Sarı M, Köstek O, Bayoğlu IV.   +18 more
europepmc   +1 more source